Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, or debt levels. It focuses exclusively on a specific share repurchase transaction:
- Date of Purchase: May 22, 2025
- Shares Purchased: 802,236 ordinary shares
- Price Range: Lowest 409.70p; Highest 415.80p
- Volume Weighted Average Price: 411.98p
- Post-Transaction Capital: 9,009,337,153 ordinary shares registered; 4,080,205 held as treasury shares.
- Voting Shares: 9,005,256,948 ordinary shares with voting rights.
Material Changes
The primary material change reported is the reduction of the company's share count due to the cancellation of 802,236 shares purchased on May 22, 2025. No other material changes to operations or financial position are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction in accordance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 buyback programme.
- Confirm the current market price relative to the 411.98p average purchase price.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Check subsequent filings for updates on the remaining capacity of the buyback programme.